Answers are grounded in this paper and cite their sources.
Neutralizing autoantibodies against interleukin-1 receptor antagonist (IL-1RA) have been identified in patients with Still's disease, often in association with hyperphosphorylation of the endogenous soluble IL-1RA protein. Although several cytokines and signaling pathways have been implicated in the pathogenesis of Still's disease, the mechanisms underlying anti-IL-1RA autoantibody production remain unclear. Their detection is challenging due to assay heterogeneity, and therefore, a combination of different detection methods is recommended. This minireview explores potential predisposing factors for IL-1RA autoantibody development and discusses their biological and clinical significance. It also summarizes current diagnostic approaches for their detection, highlighting key challenges, pitfalls, and limitations.
No takes yet. Share an insight, caveat, or question.
Abdellatif Bouayad (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: